• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瘦素和胃饥饿素浓度与帕金森病患者的体重减轻。

Leptin and ghrelin concentrations and weight loss in Parkinson's disease.

机构信息

Department of Neurology and Epileptology, Medical Center for Postgraduate Education, Warsaw, Poland.

出版信息

Acta Neurol Scand. 2010 Apr;121(4):230-6. doi: 10.1111/j.1600-0404.2009.01185.x. Epub 2009 Dec 17.

DOI:10.1111/j.1600-0404.2009.01185.x
PMID:20028343
Abstract

OBJECTIVES

To investigate the role of leptin, ghrelin, GH and IGF-1 in energy balance disturbances in Parkinson's disease (PD).

MATERIALS AND METHODS

Thirty-nine patients were included: 11 PD patients with unintentional weight loss, 16 PD patients without weight loss and 12 controls. UPDRS, MMSE, MADRS, appetite scale, BMI, adipose tissue content, plasma leptin and active ghrelin concentrations and serum GH, IGF-1, TSH, T3 and T4, concentrations were evaluated.

RESULTS

A lower plasma leptin concentration and a higher serum IGF-1 concentration were found in PD patients with weight loss. BMI and the content of adipose tissue were positively correlated with leptin concentration in all PD patients. Paradoxically, the lower BMI was, the lower plasma active ghrelin concentration was in PD patients with the weight loss.

CONCLUSION

These findings confirm that changes of plasma leptin concentration occur in PD patients with loss of weight.

摘要

目的

探讨瘦素、胃饥饿素、GH 和 IGF-1 在帕金森病(PD)能量平衡紊乱中的作用。

材料与方法

共纳入 39 例患者:11 例 PD 伴非故意体重减轻患者、16 例 PD 无体重减轻患者和 12 例对照。评估 UPDRS、MMSE、MADRS、食欲量表、BMI、脂肪组织含量、血浆瘦素和活性胃饥饿素浓度以及血清 GH、IGF-1、TSH、T3 和 T4 浓度。

结果

体重减轻的 PD 患者血浆瘦素浓度较低,血清 IGF-1 浓度较高。在所有 PD 患者中,BMI 和脂肪组织含量与瘦素浓度呈正相关。矛盾的是,体重减轻的 PD 患者的 BMI 越低,血浆活性胃饥饿素浓度越低。

结论

这些发现证实,体重减轻的 PD 患者的血浆瘦素浓度发生变化。

相似文献

1
Leptin and ghrelin concentrations and weight loss in Parkinson's disease.瘦素和胃饥饿素浓度与帕金森病患者的体重减轻。
Acta Neurol Scand. 2010 Apr;121(4):230-6. doi: 10.1111/j.1600-0404.2009.01185.x. Epub 2009 Dec 17.
2
Weight loss, body fat mass, and leptin in Parkinson's disease.帕金森病中的体重减轻、体脂量与瘦素
Mov Disord. 2009 Apr 30;24(6):885-90. doi: 10.1002/mds.22466.
3
Ghrelin - growth hormone releasing and orexigenic hormone in men declines with age, insulin and with decrease in testosterone concentration.胃饥饿素——男性体内的生长激素释放及促食欲激素——会随着年龄增长、胰岛素水平以及睾酮浓度降低而下降。
Neuro Endocrinol Lett. 2008 Feb;29(1):100-6.
4
Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones.接受姑息治疗的未选择癌症患者的身体成分以及脂肪和瘦组织区域分布的时间进程变化——与食物摄入、代谢、运动能力和激素的相关性
Cancer. 2005 May 15;103(10):2189-98. doi: 10.1002/cncr.21013.
5
Leptin and ghrelin expression in adipose tissues and serum levels in gastric banding patients.胃束带手术患者脂肪组织中瘦素和胃饥饿素的表达及血清水平
Eur J Clin Invest. 2006 Jun;36(6):389-94. doi: 10.1111/j.1365-2362.2006.01642.x.
6
Plasma and hypothalamic peptide-hormone levels regulating somatotroph function and energy balance in fed and fasted states: a comparative study in four strains of rats.进食和禁食状态下调节生长激素分泌细胞功能及能量平衡的血浆和下丘脑肽类激素水平:四种品系大鼠的比较研究
J Neuroendocrinol. 2004 Dec;16(12):980-8. doi: 10.1111/j.1365-2826.2004.01259.x.
7
Circulating ghrelin in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者体内的循环胃饥饿素
Nutrition. 2005 Jul-Aug;21(7-8):793-8. doi: 10.1016/j.nut.2004.11.015.
8
[Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].[评估不同内源性皮质醇水平人群血浆中瘦素水平及其对影响组织脂肪水平的其他激素因素的依赖性]
Ann Acad Med Stetin. 2002;48:283-300.
9
Plasma levels of active and total ghrelin in renal failure: a relationship with GH/IGF-I axis.肾衰竭患者血浆中活性及总胃饥饿素水平:与生长激素/胰岛素样生长因子-I轴的关系
Growth Horm IGF Res. 2005 Dec;15(6):369-76. doi: 10.1016/j.ghir.2005.07.004. Epub 2005 Sep 28.
10
Serum ghrelin concentrations in patients with chronic renal failure undergoing dialysis.接受透析的慢性肾衰竭患者的血清胃饥饿素浓度
Clin Endocrinol (Oxf). 2006 Jan;64(1):68-73. doi: 10.1111/j.1365-2265.2005.02418.x.

引用本文的文献

1
Fasting and postprandial Ghrelin levels in Parkinson's disease: a systematic review and meta-analysis.帕金森病患者的空腹及餐后胃饥饿素水平:一项系统评价与荟萃分析
NPJ Parkinsons Dis. 2025 Jul 14;11(1):212. doi: 10.1038/s41531-025-01066-0.
2
Vital nutrition: enhancing health in advanced Parkinson's disease with device-aided therapies.重要营养:通过设备辅助疗法改善晚期帕金森病患者的健康状况
J Neural Transm (Vienna). 2025 Apr 24. doi: 10.1007/s00702-025-02935-x.
3
Association between serum IGF‑1 levels and non-motor symptoms in Parkinson's disease.
帕金森病患者血清胰岛素样生长因子-1水平与非运动症状之间的关联
Neurol Sci. 2025 Mar;46(3):1201-1206. doi: 10.1007/s10072-024-07835-8. Epub 2024 Oct 29.
4
Unravelling the mechanisms of underweight in Parkinson's disease by investigating into the role of gut microbiome.通过研究肠道微生物群的作用来揭示帕金森病体重不足的机制。
NPJ Parkinsons Dis. 2024 Jan 24;10(1):28. doi: 10.1038/s41531-023-00587-w.
5
Impact of weight loss for depressive symptom in mid-stage patients with Parkinson's disease: a 4-year follow-up study.体重减轻对帕金森病中期患者抑郁症状的影响:一项4年随访研究
Front Neurol. 2024 Jan 5;14:1306138. doi: 10.3389/fneur.2023.1306138. eCollection 2023.
6
Targeting neuroendocrine abnormalities in Parkinson's disease with exercise.通过运动针对帕金森病中的神经内分泌异常
Front Neurosci. 2023 Sep 8;17:1228444. doi: 10.3389/fnins.2023.1228444. eCollection 2023.
7
Changes in the Secretion of Melatonin and Selected Adipokines during the Progression of Parkinson's Disease-Preliminary Studies.帕金森病进展过程中褪黑素及某些脂肪因子分泌的变化——初步研究
Metabolites. 2023 May 18;13(5):668. doi: 10.3390/metabo13050668.
8
The Interplay between Ghrelin and Microglia in Neuroinflammation: Implications for Obesity and Neurodegenerative Diseases.脑内炎症中 ghrelin 与小胶质细胞的相互作用:肥胖与神经退行性疾病的相关影响。
Int J Mol Sci. 2022 Nov 3;23(21):13432. doi: 10.3390/ijms232113432.
9
Update to the Treatment of Parkinson's Disease Based on the Gut-Brain Axis Mechanism.基于肠-脑轴机制的帕金森病治疗进展
Front Neurosci. 2022 Jul 6;16:878239. doi: 10.3389/fnins.2022.878239. eCollection 2022.
10
Gastrointestinal Dysfunction in Parkinson's Disease.帕金森病中的胃肠功能障碍
Drugs. 2022 Feb;82(2):169-197. doi: 10.1007/s40265-021-01664-1. Epub 2022 Jan 25.